Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegacorat in Duchenne Muscular Dystrophy
NCT07911995Phase 2Not yet recruiting
- Sponsor
- Grünenthal GmbH
- Start
- Nov 2026
- Primary completion
- Jan 2030
01
Overview
A Phase 2 trial of tegacorat in Duchenne muscular dystrophy (DMD), sponsored by Grünenthal GmbH. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
tegacorat
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT07911995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911995.